Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
Yasutaka YamadaShinichi SakamotoJunryo RiiSatoshi YamamotoShuhei KamadaYusuke ImamuraKazuyoshi NakamuraAkira KomiyaHiroomi NakatsuTomohiko IchikawaPublished in: The Prostate (2020)
The novel inflammatory index combining dNLR and LDH was a useful prognostic parameter in patients with mCRPC. Our analysis suggested that dNLR emerged as a more valuable prognostic marker than NLR.
Keyphrases